SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Molecular Partners to Present Initial Phase 1/2a Data on MP0712

Molecular Partners says it will present initial Phase 1/2a data on MP0712 in lung cancer and other solid tumors.

Related stories